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The E6 and E7 proteins of the high-risk human papillomaviruses (HPVs) act coordinately to immortalize human keratino-
cytes. These viral oncoproteins function by binding and altering the activity of cellular proteins which regulate cell cycle
progression. Among the proteins bound by E7 are the retinoblastoma protein, Rb, as well as the related p107 and p130
proteins. In addition, E7 binds cyclin A, which regulates transit through the S and G2/M phases of the cell cycle. In this
study, we demonstrate that HPV 18 E7 also associates with cyclin E which controls the G1/S transition. E7/cyclin E
complexes were immunoprecipitated from E7-expressing cells as well as from cell extracts using GST–E7 fusion proteins.
E7 was found to complex with a single form of cyclin E, and the binding was mediated through p107. Both E7/cyclin E and
E7/cyclin A complexes exhibit kinase activity through associated cdk2 proteins which can contribute to phosphorylation of
p107. The association of E7 with proteins which regulate transit through the cell cycle may provide an additional mechanism
by which infection with human papillomaviruses results in cellular hyperproliferation. q 1996 Academic Press, Inc.
INTRODUCTION tive dissociation of E2F leading to the deregulated ex-
pression of E2F-responsive genes (Nevins, 1992). Mu-
Human papillomaviruses are the etiologic agents of
tants of E7 have been identified which are deficient for
cervical cancer (zur Hausen, 1985), and their major trans-
Rb binding but retain the ability to immortalize primary
forming functions are encoded by the E6 and E7 open
human keratinocytes (Jewers et al., 1992). Additional
reading frames. Both the E6 and E7 proteins are capable
studies have shown that E7 mutants which are unable
of transforming rodent fibroblasts (Bedell et al., 1989;
to bind zinc but retain wild-type Rb binding activity are
Edmonds and Vousden, 1989; Phelps et al., 1988), and
incapable of transforming cells in culture (McIntyre et al.,
the coordinate action of both proteins is required for
1993). Taken together, these studies suggest that E7 may
the immortalization of human keratinocytes (Kaur and
target other cell cycle-dependent processes.
McDougal, 1988; Munger et al., 1989). The E6 protein
The additional activities of E7 most likely involve inter-
binds the p53 protein and targets it for degradation
action with other cellular proteins, such as p107 and
through a ubiquitin-mediated pathway (Crook et al., 1991;
p130 which are also involved in growth regulation (Dyson
Scheffner et al., 1990). The E7 protein alters normal
et al., 1992; Ewen et al., 1992; Li et al., 1993). Both p107
growth control by binding a set of cellular proteins includ-
and p130 bind members of the E2F family in a mannering the retinoblastoma protein, Rb (Dyson et al., 1989).
similar to Rb and contribute to the cell-cycle-dependentSimilar activities have been demonstrated for the adeno-
regulation of transcription (Schwarz et al., 1993; Cobrinikvirus E1A protein and SV40 large T antigen (DeCaprio et
et al., 1993). Unlike Rb, p130 and p107 also bind andal., 1988; Whyte et al., 1988) which share two regions of
are phosphorylated by cyclin A–cdk2 and cyclin E–cdk2homology with E7, termed CR1 and CR2. These regions
complexes (Ewen et al., 1992; Faha et al., 1992; Hannonare essential for Rb binding as well as transformation. In
et al., 1993; Lees et al., 1992; Li et al., 1993). Cyclinnontransformed cells, E2F transcription factors associate
proteins activate a family of cyclin-dependent kinases atwith Rb in early G1 and dissociate upon phosphorylation
specific points in the cell cycle. While cyclin A activatesof Rb in late G1 (reviewed in Nevins, 1992). This dissocia-
cdk2 and cdc2 during S and G2/M phases, respectively,tion results in the activation of E2F-dependent genes
cyclin E activates cdk2 primarily during the G1/S transi-which include those involved in DNA replication. The
tion (Hunter, 1993; Scherr, 1993). These cyclin complexesbinding of viral oncoproteins to Rb results in the constitu-
modulate the activity of other cell cycle regulators, such
as Rb, through phosphorylation. Transforming proteins
1 Current address: INSERM U370, 156 Rue du Vaugirard, Paris,
from the DNA tumor viruses specifically target cyclinFrance 75015.
complexes. While E1A associates with both cyclins A2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 503-1339. and E, T-antigen and E7 have only been reported to bind
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cyclin A (Adamczewski et al., 1993; Arroyo et al., 1993; HE12 used in Western blots was a gift of Emma Lees
(Massachusetts General Hospital Cancer Center; Bos-Faha et al., 1993; Pines and Hunter, 1990; Tommassino
et al., 1993). In this study, we have investigated whether ton, MA). The anti-cyclin E monoclonal antibody HE111
used in kinase assays was also a gift of Emma Lees andthe E7 protein from the high-risk HPV type 18 forms a
complex with cyclin E which regulates transit from G1 later was purchased as an agarose conjugate (Santa
Cruz Biotechnologies, Santa Cruz, CA) for use in pre-to S.
clearing synchronized cell extracts. The polyclonal anti-
cyclin A antibody was a gift from Tony Hunter. Anti-p107MATERIALS AND METHODS
monoclonal antibody SD-9 was a gift of Nicholas Dyson
(Massachusetts General Hospital Cancer Center). TheMutagenesis of the CR1 and CR2 domains of HPV-18
E7. Mutations were introduced into the HPV-18 E7 gene polyclonal antibody M-2, used to visualize cdk2 in West-
ern blots was purchased from Santa Cruz Biotechnolo-by recombinant PCR techniques as described (McIntyre
et al., 1993) and the mutant sequences were cloned into gies. Purified polyclonal anti-E7 antibody affE7 (McIntyre
et al., 1993) was used for in vitro binding studies. Poly-the vector pSG5 to create CR1 mutant pS2H2P (amino
acid 2 changed to proline) and the CR2 mutants pS27C2G clonal antibody 247 was raised against the peptide
CEARIELVVESSA, corresponding to amino acids 68 to(amino acid 27 changed to a glycine), pSDDLLC (amino
acids 24–27 are deleted), pSDDLLC31F (amino acids 82 of HPV-18 E7, which was linked to keyhole limpet
hemocyanin (KLH) by standard techniques (Harlow and24–27 are deleted and 31 changed to phenylalanine),
and pSDDLLC20K (amino acids 24–27 are deleted and Lane, 1988). E7-specific antibody was affinity purified
against a GST–E7 column as described in (Koff et al.,20 changed to glutamic acid).
Construction of wild-type and mutant GST–E7 fusion 1992) and then cross-linked to protein A–Sepharose with
dimethylpimelidate (Harlow and Lane, 1988).expression constructs. The E7 gene was fused to the
glutathione S-transferase gene to facilitate the one-step Cell culture. The HaCat and C33a cell lines were main-
tained in DMEM (JRH Biosciences, Lenexa, KS) with 10%purification of the fusion protein (Smith et al., 1988).
pGSTE7 was constructed by digesting pETE7 (McIntyre fetal bovine serum (Gibco-BRL, Grand Island, NY). Pri-
mary human foreskin keratinocytes were grown in KGMet al., 1993) with NcoI and EcoRV and ligating this frag-
ment into the plasmid pGex-KG (Guan and Dixon, 1991), (Clonetics, San Diego, CA).
Identification of cellular proteins bound to GST–E7 viawhich had been digested with HindIII, filled in with
Klenow, and then digested with NcoI. Plasmids immunoblot. Asynchronously dividing cultures of primary
human foreskin keratinocytes, C33a, or HaCat cells werepGST27C2G, pGSTDDLLC, pGSTDDLLC20K, and
pGSTDDLLC31F were constructed by amplifying the mu- harvested as above. Five milligrams of thawed extract
was precleared with 8 mg GST and 100 ml of glutathione –tant E7-containing sequences from the constructs de-
scribed above using synthetic oligonucleotides which agarose and then mixed with 5 mg GST–E7 or GST.
Protein complexes were precipitated with 25 ml of gluta-add an NcoI site to the 5* end of the gene and a BamHI
site to the 3* end. The BamHI site was filled in with thione–agarose, separated by SDS–polyacrylamide gel,
and transferred to a PVDF filter. The filter was thenKlenow and the fragment was cloned into pGex-Kg as
described above. probed with antibodies to cyclin E, cyclin A, p107, or Rb.
Horseradish peroxidase-linked anti-rabbit or anti-mouseOther expression plasmids. The GST–p107 fusion pro-
tein was expressed from the plasmid GST107 (23), a antibody was used as the secondary antibody, and anti-
gen–antibody complexes were visualized via the ECLgift of Mark Ewen (Dana-Farber Cancer Institute, Boston,
MA). The plasmid Gex-E (Koff et al., 1991), which ex- (Amersham, Arlington Heights, IL) chemiluminescent de-
tection system.pressed a GST–cyclin E fusion, was a gift of James Rob-
erts (Fred Hutchinson Cancer Research Center, Seattle, To determine the cell cycle specificity of the interaction
of cellular proteins with GST–E7, 5 mg of extract fromWA). The cyclin E gene was cloned into the plasmid
pBluescript by digesting the cyclin E gene from GEX-E C33a cells that had been synchronized and harvested
as detailed above was mixed with 5 mg GST–E7 andwith SmaI and PstI and cloning into the SmaI and PstI
sites of pBluescript. The cyclin B cDNA clone in the vec- processed as described below. The filter was cut into
strips to separate proteins of different molecular weightstor pGem4Z, pCyclin B (Pines and Hunter, 1990), was the
gift of Tony Hunter (Salk Institute, La Jolla, CA). and the appropriate strip was probed with antibodies to
cyclin E, p107, or cdk2. The intensity of the chemilumines-Expression of GST fusion proteins. GSTE7,
GSTDDLLC, GST20KDDLLC, and GSTDDLLC31F were cent signal at each time point was determined by laser
scanning densitometry (Molecular Dynamics, Sunny-expressed and purified as described (Guan and Dixon,
1991). GST–p107, GST–cyclin E, and GST–27C2GE7 vale, CA).
In vivo association. C33a cells were infected with thewere expressed and purified as described (Koff et al.,
1992). E7 expressing retrovirus pMV718E7 or the parental virus
pMV7 (Gifts of Nissim Hay) and selected with 1 mg/mlAntibodies. The monoclonal anti-cyclin E antibody
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G418 for 1 week to generate the cell lines C3318E7 and were prepared and mixed with 1 mg wild-type or mutant
GST–E7 as described for the immunoblots. Cyclin E wasC33pMV7. Extracts from these cell lines, C33a, or HeLa
cells were prepared as described and mixed with protein also precipitated from extracts with the anti-cyclin E anti-
body HE111. Beads were washed twice with ELB andA–Sepharose-conjugated anti-cyclin E or anti-E7 anti-
body. Bound proteins were resolved by SDS–PAGE, then twice more with kinase buffer (50 mM HEPES, pH
7.0, 15 mM MgCl2 , 1 mM DTT) plus 0.1 mg/ml BSA. Ki-transferred to Immobilon-P membranes, and analyzed by
immunoblotting. nase reactions were then performed in 50 ml kinase
buffer with 10 mCi [g-32P]ATP and 25 mM cold ATP at 307In vitro mixing of E7 with GST–p107 and GST–cyclin
E. Five micrograms of bacterial-expressed, nonfused E7 for 30 min. Reactions were stopped by the addition of
an equal volume of 41 Laemmli sample buffer and sepa-(McIntyre et al., 1993) was mixed with 0.25, 0.5, 1, or 5
mg GST–p107 or GST–cyclin E in a total of 200 ml ELB. rated on a 7.5% SDS–PAGE gel. Labeled proteins were
visualized by autoradiography.After mixing for 1.5 hr at 47, complexes were collected
with 25 ml glutathione– agarose. Bound protein was Histone H1 kinase activity following cyclin antibody
preclearing. Five hundred micrograms of cell extract waseluted in sample buffer, electrophoresed on a 12.5%
SDS–polyacrylamide gel, and transferred to nitrocellu- precleared twice with cyclin A antibody BF683 (Santa
Cruz), cyclin E antibody HE111 (Santa Cruz), or purifiedlose. The blot was probed with affE7 using an alkaline
phosphatase-conjugated goat anti-rabbit antibody as the mouse IgG1 isotype control 03001D (PharMingen) and
immune complexes were collected with protein G–Seph-secondary antibody. Complexes were visualized colori-
metrically with an alkaline phosphatase conjugate sub- arose (Pharmacia) before determining the kinase activity
associated with GSTE7, GST, cyclin A, and cyclin E usingstrate development kit (Bio-Rad, Hercules, CA).
Coprecipitation of in vitro translated cyclin E with GST – histone H1 as a substrate by previously described meth-
ods (Koff et al., 1991). Following SDS–PAGE and autora-E7. Cyclins E and B were transcribed and translated in
vitro with the TNT Coupled Reticulocyte Lysate system diography, radioactivity incorporated into histone H1 was
quantitated by a phosphorimager (Fuji, Japan).(Promega, Madison, WI) to produce [35S]methionine-la-
beled proteins. Twenty-five microliters of each translation
reaction was mixed with 1 mg of GST–E7 and 5 mg GST – RESULTS
p107 or GST in a total volume of 300 ml ELB. Mixtures
were precleared with 100 ml protein A–Sepharose in ELB Cyclins A and E bind GST–E7. To investigate if cyclin
E can associate with HPV 18 E7, we examined the abilityand then the complexes were precipitated with affE7 and
25 ml protein A beads. Bound proteins were separated of proteins from cell extracts to bind to an N-terminal
fusion of E7 with glutathione S-transferase (GST–E7).by SDS–PAGE and labeled cyclins E and B coprecipitat-
ing with GST–E7 were visualized on a phosphorimager For these studies, equal amounts of purified bacterially
expressed GST–E7 fusion protein were mixed with unla-(Molecular Dynamics, Sunnyvale, CA).
Synchronization of C33a cells. C33a cells were syn- beled extracts from a variety of HPV-negative human epi-
thelial cells including normal human foreskin keratino-chronized at the G1/S boundary by treating with 2 mM
mimosine (Sigma, St. Louis, MO) for 18 hr. Upon removal cytes (HFK), HaCat and C33a cells. Proteins bound to
GST–E7 were then examined by Western blot analysisof the drug, cells were either harvested or refed with
medium without mimosine. Cells were harvested every using antibodies to cyclin E. Three forms of cyclin E with
molecular weights of 45 to 55 kDa were observed in2 hr for a total of 16 hr subsequent to the removal of the
drug and lysed in 1 ml ELB lysis buffer (72) (50 mM whole cell extracts (WCE) of HFK or C33a cells (Fig. 1A),
consistent with previous observations (Koff et al., 1991;HEPES, pH 7.0, 250 mM NaCl, 5 mM EDTA, 10 mM ZnCl2 ,
100 mM NaF, 200 mM Na3-o-VO4 , 1 mM DTT, 1 mM Dulic et al., 1992). In contrast, in the HaCat cell line, only
a single predominant form of cyclin E was observed (Fig.PMSF, 1 mM benzamidine HCl, 1 mg/ml pepstatin, 1
mg/ml leupeptin, 0.5% NP-40) per plate. Clarified lysates 1A). GST–E7 was found to preferentially bind the slowest
migrating form of cyclin E, while only a low level of asso-were stored at 0807. Duplicate plates of cells were syn-
chronized in the same manner but fixed in 75% ethanol ciation was observed with the other forms (Fig. 1A). This
preferential association was observed in extracts fromfor cell cycle analysis. Prior to analysis, fixed cells were
pelleted and resuspended in propidium iodide staining all three cell lines. The ability of GST–E7 to bind cyclin
A was also examined by a similar protocol and the resultsbuffer (3.8 mM sodium citrate, 0.125 mg/ml RNase A, 10
mg/ml propidium iodide). After 1 hr, the DNA content are shown in Fig. 1B. The association of GST–E7 with
cyclin A was observed in extracts from all three cell linesof the cells was determined by flow cytometry using a
fluorescence-activated cell sorter (FACS) and CellFit soft- consistent with previous observations (Tommassino et
al., 1993). Similarly, the association of E7 with p107 wasware.
Kinase assays. To determine the kinase activity associ- also observed as previously reported (Davies et al., 1993;
Ciccolini et al., 1994) with the highest level of bindingated with wild-type and mutant GST–E7 fusion proteins,
1-mg extracts of asynchronously growing C33a cells detected in C33a cells (not shown).
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by Western analysis. All three forms of cyclin E were
immunoprecipitated with cyclin E antibodies (HE111)
from HeLa and C33a cells (Fig. 2A). Using antibodies
to E7, a specific association was detected between the
endogenous E7 and the slowest migrating form of cyclin
E in HeLa cells, consistent with our observations using
GST–E7. No cyclin E proteins were immunoprecipitated
with the E7 antibody from C33a cells which do not ex-
press E7 (Fig. 2A). A similar association of the slowest
migrating form of cyclin E with E7 was also observed in
immunoprecipitations of pMV7–18E7 cells but was not
found in cells which had been infected with a control
retrovirus (pMV7; Fig. 2B). We next examined if the ki-
nase, cdk2, which is usually found in association with
cyclin E, was also present in complexes with E7. The
FIG. 1. Western blot analysis of cyclin E and cyclin A bound by GST– Western blot shown in Fig. 2B was reprobed with anti-
E7 in a variety of cell lines. (A) Multiple forms of cyclin E present in bodies to cdk2, and the presence of cdk2 in association
whole cell extracts (WCE) from human foreskin keratinocytes (HFK), with E7 was observed (Fig. 2B). It is likely that the binding
HaCat, and C33a are shown. Proteins precipitated by GST–E7 or GST
of cdk2 occurs through the association of E7 with bothare indicated. Following separation by SDS–polyacrylamide gel elec-
cyclins E and A. We were unable to coprecipitate signifi-trophoresis, proteins were transferred to a membrane and probed with
antibodies to cyclin E. (B) Similar analyses as in A but with antibodies cant levels of E7 with antibodies to cyclin E (Fig. 2B)
to cyclin A. Proteins were visualized via chemiluminescence using which may be the result of low levels of interaction or
horseradish peroxidase-conjugated secondary antibodies. blocked epitopes. The experiments described above
demonstrated that we could precipitate a complex of E7
and cyclin E from cell lines, which confirmed our previousCyclin E binds E7 in vivo. While GST fusion methodolo-
observations using GST fusion proteins. Since the usegies provided a simple way of studying E7-associated
of immunoprecipitations to study E7/cyclin E interactionsproteins, it was important to further confirm that the bind-
was not efficient, we chose to use GST–E7 proteins foring of cyclin E to E7 occurred in vivo. Therefore, we
the subsequent studies.performed immunoprecipitation analyses using HeLa
E7 associates with cyclin E through p107. We nextcells, which express HPV 18 E6 and E7, as well as
examined the ability of E7 and cyclin E to interact directlypMV7–18E7 cells, which were derived following infection
in vitro using purified, nonfused E7 and GST–cyclin E.of C33a cells with E7-expressing amphotropic retrovi-
As a positive control, we first examined the binding ofruses. Cell lysates were incubated with affinity-purified
GST–p107 to purified E7. The amount of E7 bound byantibodies directed against the C-terminus of E7 (247) or
GST–p107 was found to correlate with input levels (Fig.antibodies directed against cyclin E (HE111). Following
immunoprecipitation, the bound proteins were examined 3A), but no E7 protein was bound by either GST–cyclin
FIG. 2. Cyclin E and HPV 18 E7 associate in vivo. (A) HPV 18 E7 or cyclin E proteins were immunoprecipitated from HeLa cells with anti-E7
antibody 247 or anti-cyclin E antibody HE111. Proteins were separated by SDS–PAGE, transferred to a membrane, and identified by probing with
anti-cyclin E or anti-E7 antibodies followed by visualization with chemiluminescence. Multiple forms of cyclin E are indicated and E7 associates
with the slowest migrating form. (B) Extracts from C33a cells infected with the HPV 18 E7 expressing retrovirus pMV7–18E7 or parent virus pMV7
were immunoprecipitated with antibodies to E7 or cyclin E as described under Materials and Methods. Associated proteins were identified by
Western analysis using anti-cyclin E, anti-E7, or anti-cdk2 antibodies.
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of nonspecific binding was observed that was similar in
amount to that seen with GST alone. No increase in
cyclin B binding was observed upon the further addition
of GST–p107. The E7 antibodies also failed to precipitate
GST–p107/cyclin E complexes in the absence of added
GST–E7 (not shown). We conclude that cyclin E binds
E7 indirectly through p107.
Cell cycle dependence of E7 association with p107
and cyclin E. Since the levels of cyclin E vary throughout
the cell cycle, we next investigated the distribution of E7
binding activities during the cell cycle. For these studies,
C33a cells were synchronized in late G1 with the drug
mimosine and then released by the addition of medium
lacking the drug. Cellular extracts were prepared every
2 hr following release for a total of 16 hr, and FACS
analysis of control cells confirmed that the majority of
the cells were in G1 after treatment with the drug (Fig.
FIG. 3. In vitro association between purified E7 and p107 or cyclin 4). Following release from the block, the cells progressed
E. (A) Bacterial expressed and purified E7 was mixed with increasing synchronously into S phase at 8 hr, and after 14 hr the
amounts of GST–p107 or GST – cyclin E. E7 protein was also mixed
majority of the cells were in G2/M. Cell extracts werewith GST as a control. Complexes were precipitated with glutathione
prepared at the various time points and mixed with GST –agarose and bound E7 was detected by Western analysis. Lane 1
shows input E7. (B) Cyclins E and B were translated in vitro and labeled E7, complexes were isolated, and the levels of bound
with [35S]methionine. Labeled proteins were mixed with GST–E7 and p107 and cyclin E were examined by Western blot analy-
GST –p107 or GST. Complexes were immunoprecipitated with affE7 sis. p107 was found to bind GST–E7 at a relatively con-
and separated by SDS–PAGE. Labeled protein bound to E7 was visual-
stant level through the early part of the cell cycle butized with a Molecular Dynamics phosphorimager.
diminished when cells entered G2/M (Fig. 4A). This cor-
related with a general decrease in the total level of p107
in the cells in G2/M and further demonstrated that asso-E or the GST control. This suggested that E7 and cyclin
E do not bind directly. By SDS–polyacrylamide gel analy- ciation of E7/p107 is important for cyclin E binding. Simi-
lar to our previous observations, E7 was found to bindsis, the majority of GST–cyclin E in our preparations was
full length excluding the possibility that proteolysis of the only the slowest migrating form of cyclin E which was
highest from G1 through S and this binding was signifi-E7 binding domain could be responsible for the failure
of the two proteins to form a complex (data not shown). cantly reduced in G2/M (Fig. 4B). Cdk2 was observed to
bind to E7 at a constant level at all time points examinedOur studies examining the binding of cyclin E to GST –
E7 in different cell extracts demonstrated the highest (Fig. 4C) and reflects contributions of both E7/cyclin A
and E7/cyclin E complexes.level of association in C33a cell extracts (not shown),
which also contained significant amounts of p107 (Lees E7/cyclin E complexes phosphorylate p107. The HPV
16 E7 protein has previously been reported to exhibit aet al., 1992). This indicated that p107 might play a role
in cyclin E/E7 complex formation similar to what has kinase activity that is dependent upon sequences within
the CR2 domain (Davies et al., 1993). Based on our find-been suggested previously for cyclin A binding to E1A
(Faha et al., 1992). To determine if p107 mediates the ings this activity could be due either to the binding of
cyclin A/cdk2, cyclin E/cdk2, or both. Since our analysesassociation of E7 with cyclin E, in vitro translated cyclin
E was mixed with GST– E7 in the presence or absence indicated that E7 bound cyclin E through p107, it seemed
possible that the loss of kinase activity associated withof GST–p107 and complexes were immunoprecipitated
with E7 polyclonal antibodies. Consistent with the above mutations in CR2 could be due to an inability to bind
p107 and consequently cyclin E. To test this hypothesis,observations, GST–E7 did not bind in vitro translated
cyclin E above background levels observed with GST HPV 18 E7 CR2 mutants were constructed which were
similar to the previously described HPV 16 E7 mutantsalone (Fig. 3B). In contrast, the addition of GST–p107
was found to dramatically increase the amount of cyclin (Davies et al., 1993). These mutants were examined for
their ability to bind GST–p107 using in vitro translationE that was coprecipitated with E7 (Fig. 3B, compare lanes
1 and 2). The faster migrating species bound by p107 assays. Similar to results obtained with HPV 16, mutants
of HPV 18 E7 in the CR1 domain and the C-terminal zincseen in lane 2 are truncated cyclin E products which are
most likely the result of internal initiation of translation. finger region retained p107 binding activity (Figs. 5A and
5B). In contrast, mutants containing deletions in the RbTo control for nonspecific binding, cyclin B, which does
not bind E7, was translated in vitro and examined for its binding domain (DDLLC) as well as changes at amino
acid 27 (27C2G) were unable to bind p107 efficientlyability to bind GST–E7. As seen in Fig. 3B, a low level
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FIG. 4. Analysis of changes in the levels of p107 (A), cyclin E (B), and cdk2 (C) throughout the cell cycle as well as changes in their association
with GST–E7. Extracts of C33a cells that had been blocked at the G1/S boundary with mimosine and then released from the block for the indicated
periods of time were incubated with the various GST–E7 proteins. ‘‘A’’ designates asynchronously dividing cells. Whole cell lysates from the different
time points were analyzed by Western analysis with the corresponding antibody to p107, cdk2, or cyclin E. Proteins associated with GST–E7 were
precipitated and analyzed in a similar manner. Proteins were visualized by chemiluminescence. The changes in the intensity of the signal at the
different time points were determined by laser scanning densitometry and are presented in bar graph form. (D) Cell cycle distribution of cells as
determined by FACS analysis.
(Figs. 5A and 5B). The corresponding GST fusions of mate to be greater than 150 kDa. These proteins were
also phosphorylated in immunoprecipitated cyclin E com-these E7 mutants were then constructed and used to
plexes (Fig. 5C), which phosphorylated additional uniden-examine the kinase activities of E7-associated proteins.
tified cellular proteins.Equivalent amounts of purified GST–E7 proteins were
mixed with extracts from C33a cells, and precipitated E7 The GST–E7 mutants lost some or all associated ki-
complexes were examined for kinase activity following nase activity depending on the particular amino acids
the addition of labeled g-ATP. The pattern of phosphory- that were modified (Figs. 5B and 5C). The loss of p107
lation of proteins complexed with wild-type and mutant phosphorylation was observed in all CR2 mutants exam-
GST–E7 proteins is shown in Fig. 5C. Among the phos- ined and correlated with the inability to bind p107 in vitro
phorylated proteins bound to wild-type E7 are proteins (Figs. 5B and 5C). Similar correlations of kinase activity
of molecular weight consistent with p107, p130, and an with binding of p107 were observed by Davies et al.
(1993) using histone H1 as a substrate. Phosphorylationunidentified protein of molecular weight which we esti-
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FIG. 5. Kinase activity associated with wild-type and mutant E7 proteins when mixed with extracts of C33a cells. (A) Locations of mutations
introduced into HPV 18 E7. (B) Ability of E7 mutants to bind GST–p107. RNAs encoding mutant E7 genes were translated in vitro and labeled
proteins mixed with GST–p107. Precipitated proteins were examined by autoradiography following precipitation and SDS–PAGE. (C) The indicated
wild-type and GST–mutant E7 fusion proteins were mixed with extracts of asynchronously dividing C33a cells, complexes were precipitated with
glutathione agarose, and in vitro kinase assays were performed. Similar kinase assays were performed on immune complexes using a control
antibody (C), or anti-cyclin E. Phosphorylated proteins were separated by polyacrylamide gel electrophoresis and visualized by autoradiography.
Molecular weight markers (80, 106, and 205 kDa) are shown to the left, and phosphorylated p107 and p130 are indicated by arrows.
of p130 was observed at a very low level with the GST – When extracts were precleared two times with cyclin E
antibodies prior to assaying for histone H1 kinase activ-DDLLC / 31 mutant but was not seen with the deletion
mutants GST–DDLLC and GST–DDLLC / 20K. The ity, the cyclin E-associated kinase activity was reduced
by approximately 85% (Fig. 6). The kinase activity associ-ability to bind and phosphorylate the novel 150-kDa pro-
tein was lost with the GST–27C2G and GST–DDLLC / ated with E7 was next examined following incubation of
extracts with GST–E7 and precipitation with glutathione31F mutants. This indicates that the sequences required
by HPV 18 E7 to bind p107 may be slightly different than beads. The total kinase activity associated with E7 by
this method was found to be approximately 20% the activ-those required to bind p130 and p150. Similar patterns
ity seen in cyclin E immunoprecipitates. When keratino-of phosphorylation of E7-associated proteins were also
cyte extracts were first precleared twice with cyclin Eseen with extracts of normal human keratinocytes, al-
antibodies, E7-associated kinase activity was reducedthough the level of GST–E7-associated p107 phosphory-
by 43% (Fig. 6). However, when similar extracts werelation was reduced due to the lower levels of p107 ex-
precleared with cyclin A antibodies, the E7-associatedpression in these cells (data not shown). These studies
kinase activity decreased by 30%. The residual activitydemonstrate that p107 and p130 protein binding corre-
associated with E7 following preclearing with cyclin Elates with kinase activity of complexed proteins as well
antibodies could be the result of cyclin A/cdk2, unclearedwith histone H1 activity.
cyclin E/cdk2, or other as yet unidentified kinases. WeA significant portion of E7-associated kinase activity
therefore conclude that a significant portion of the kinaseis dependent upon bound cyclin E. We next sought to
activity that is associated with E7 is due to the bindingdetermine the contribution of E7/cyclin E/cdk2 com-
of cyclin E/cdk2.plexes to the total kinase activity associated with E7. For
these studies, we used histone H1 as a substrate since
it was easily quantifiable by phosphoimager analysis fol- DISCUSSION
lowing SDS–PAGE and has been used extensively in
previous studies (Koff et al., 1992). The relative histone The binding of cellular factors by the E7 proteins from
H1 kinase activities of cyclin E and A complexes from the high-risk HPV types is critical to the processes of
normal human keratinocytes were first compared follow- transformation and viral pathogenesis. Among the pro-
ing immunoprecipitation of cell extracts with the corre- teins which E7 binds is the retinoblastoma protein, Rb,
sponding antibodies (Fig. 6). Consistent with the majority as well as p130, p107, and cyclin A. In this study, we
of cells being in G0/G1, cyclin E-associated kinase activ- have identified cyclin E as another E7-associated protein.
E7 does not bind cyclin E directly, but appears to bindity was found to be greater than cyclin A activity (Fig. 6).
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FIG. 6. Cyclin E kinase activity associated with E7. Whole cell extracts from normal human foreskin keratinocytes were precleared twice with
either antibodies to cyclin A (aA), cyclin E (aE), or nonspecific antibodies (NS). The precleared extracts were then subjected to a final precipitation
using either the cyclin antibodies, GST, or GST–E7. Precipitated complexes were incubated with histone H1 and labeled ATP and then the amount
of H1 phosphorylated was examined following separation on an SDS–polyacrylamide gel. The amount of H1 phosphorylation was determined by
phosphoimager (Fuji, Japan) analysis and is indicated below each lane.
indirectly through p107. This observation contrasts with Several possibilities exist for the function of E7/cyclin E/
cdk2 complexes. For instance, these complexes couldthe direct binding of cyclin A to E7 (Tommassino et al.,
1993). Several alternatively spliced forms of cyclin E are alter the normal time during the cell cycle at which the
cyclin/kinase is active. Alternatively, the spectrum of pro-found in cells and E7 was found to associate with only
the slowest migrating species. Since the function of the teins phosphorylated by the kinase complexes could be
modified and in particular new proteins could be phos-various forms of cyclin E has not yet been established,
the significance of this specific association is not under- phorylated by the E7 complexes. Another function of E7
binding to cyclin E complexes could be to alter the actionstood. Cdk2 was also found in association with E7 which
is consistent with the observed E7-associated kinase of cyclin/cdk2 regulatory proteins such as the recently
identified p21 protein. Following exposure of cells to DNAactivity. Among the proteins found to be phosphorylated
by the cyclin E/E7/cdk2 complex were proteins of molec- damaging agents or radiation, p53 levels increase which
results in the activation of p21 expression. Increases inular weights consistent with p107 and p130 as well as
an unidentified protein with a molecular weight of ap- p21 levels result in repression of cyclin/cdk2 kinase ac-
tivity leading to cell cycle arrest (El-Diery et al., 1993).proximately 150 kDa. Our identification of these proteins
is based primarily on similarities of molecular weight. E6-expressing cells contain reduced levels of p53 and
fail to undergo cell cycle arrest following radiation treat-The phosphorylation of p130 and p150 by the E7-associ-
ated kinase was observed with several E7 mutants which ment (Kessis et al., 1993) due to an absence of p21.
Interestingly, cells expressing E7 alone also fail to un-had lost the ability to bind p107 indicating that additional
kinases are associated with E7 in the absence of p107 dergo cell cycle arrest following radiation treatment (De-
mers et al., 1994; Slebos et al., 1993) suggesting that E7interaction. One possibility is that p130 and p150 also
associate with cyclin E/cdk2 or cyclin A/cdk2 complexes by itself may alter the cyclin response to kinase regula-
tory proteins.and that they provide the residual kinase activity. Alterna-
tively, it is possible that an unidentified kinase binds E7 One identified target of cyclin E/E7/cdk2 activity ap-
pears to be p107, and the resultant interactions may beand is responsible for p130 and p150 phosphorylation.
The observation of a novel cellular protein, p150, which important for transcriptional control. Lam et al. (1994)
examined cells expressing E7 for the expression of b-binds to sequences within the Rb binding domain of E7
suggests that it may represent a previously uncharacter- myb, which is normally dependent on E2F-responsive
sites bound by the S-phase-specific p107/cyclin A/E2Fized member of the Rb-related protein family.
The functional significance of E7’s association with complex. In these cells b-myb expression was deregu-
lated and no longer cell cycle dependent. The phosphory-cyclin E most likely centers on the kinase activity of the
complex. Preliminary data suggest that the cyclin E/cdk2/ lation of p107 by E7 complexes could provide a mecha-
nism for this activity. In contrast to the binding of E7 toE7 complex exhibits kinase activity throughout the cell
cycle with a slight peak at S while the E7/cyclin A/cdk2 Rb, the association of E7 with p107 does not result in
dissociation of E2F. Instead, E2F remains complexedkinase is most active in G2/M (McIntyre and Laimins,
unpublished data). These observations are in agreement with p107/E7 (Arroyo et al., 1993; Lam et al., 1994) which
suggests that E7 may alter the p107-mediated regulationwith studies involving E1A, which demonstrated a kinase
activity during both S phase and G2/M due to contribu- of E2F by alternative mechanisms such as through
changes in phosphorylation. Such alterations could con-tions from both cyclin A–cdk2 complexes and cyclin E–
cdk2 complexes (Faha et al., 1993; Giordano et al., 1991). tribute to transformation as well as to the normal activity
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papillomavirus-16 E7 oncoprotein is able to bind the retinoblastomaof E7 during a viral infection. In normal epithelia, cellular
gene product. Science 243, 934–936.replication is limited to basal cells, and nuclei are de-
Dyson, N., Guida, P., Munger, K., and Harlow, E. (1992). Homologousgraded as cells differentiate. In an HPV infection, basal sequences in adenovirus E1a and human papillomavirus E7 proteins
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Edmonds, C., and Vousden, K. H. (1989). A point mutational analysisintact. In the suprabasal region, infected cells are most
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